News

Gemstone Biotherapeutics, a biotech company developing novel, bioengineered products for scar-free skin regeneration, today announced that Dr. Emily English has been named Chief Executive Officer and Heather Keith has joined the company as Director of Sales and...

Janty Shoga joined the Gemstone Biotherapeutics team as research engineer in November of 2017. In this role, Janty contributes to the entire portfolio of skin regeneration solutions. He has extensive wetlab, microscopy and prototyping experience. With a Bachelor’s...

Gemstone is excited to welcome Teresa Compton, PhD, Ronald Sherman, DPM, and Marc Dauer, MD, as members of the scientific advisory board. Dr. Compton, former VP of Translational Medicine and Virology for Biogen Idec and former Executive Director at Novartis, brings...

Gemstone inventors, Drs. Abadir and Walston, published in the Journal of Investigative Dermatology that a common class of medications block inflammation pathways and speeds healing of chronic wounds when applied topically. “The FDA has not issued any new drug approval for wound healing in the past 10 years,” says Abadir. “…we think we have shown that this class of medicines holds great promise in effectively healing chronic wounds that are prevalent in diabetic and aged patients.”